Long Yuan, a former colleague of mine, and a few current colleagues recently published a method for double-stranded siRNA using hybridization extraction and LC-MS/MS. Long reports the first hybridization method for double stranded siRNA using conventional DNA capture probes, as well as, a peptide nucleic acid (PNA) capture probe. The PNA has a higher affinity for the siRNA and therefore, has greater recovery efficiency (and was proven experimentally). To optimize the LC-MS/MS conditions, they used the active antisense siRNA strand. However for the calibration curve and QCs the double-stranded siSNA was used. A typical BMV validation was used. The calibration curve was 2-1000 ng/ML and the s/n at the LLOQ appeared to be >10. They tested monkey plasma, CSF and 8 different tissues. Using the PNA probe, they achieved around 90% recovery - demonstrating the viability of the approach for this and other double-stranded siRNA therapies. More details are in the article.
Information and interesting ideas
Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.
Subscribe to:
Post Comments (Atom)
FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made
This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...
-
FDA has released an app - " Drugs@FDA includes most of the drug products approved since 1939. The majority of patient information, l...
-
If you have or haven't looked at the ICH E6 revision 3 GCP guideline, this may be of interest to see how others perceive the difference...
-
Post-BREXIT, the UKs MHRA joined ICH as an independent body in May 2022. This notification on the Agency's Blog provides an overview o...
No comments:
Post a Comment